DK1075837T3 - Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse - Google Patents

Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse

Info

Publication number
DK1075837T3
DK1075837T3 DK99125642T DK99125642T DK1075837T3 DK 1075837 T3 DK1075837 T3 DK 1075837T3 DK 99125642 T DK99125642 T DK 99125642T DK 99125642 T DK99125642 T DK 99125642T DK 1075837 T3 DK1075837 T3 DK 1075837T3
Authority
DK
Denmark
Prior art keywords
aqueous formulations
ophthalmic use
preparing aqueous
ophthalmic
formulations
Prior art date
Application number
DK99125642T
Other languages
English (en)
Inventor
Antonino Asero
Maria Grazia Mazzone
Valeria Moschetti
Anna Rita Blanco
Original Assignee
S I F I Societa Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I F I Societa Ind Farmaceuti filed Critical S I F I Societa Ind Farmaceuti
Application granted granted Critical
Publication of DK1075837T3 publication Critical patent/DK1075837T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99125642T 1999-08-09 1999-12-22 Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse DK1075837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001803A IT1313610B1 (it) 1999-08-09 1999-08-09 Processo per la preparazione di formulazioni acquose per uso oftalmico

Publications (1)

Publication Number Publication Date
DK1075837T3 true DK1075837T3 (da) 2003-09-01

Family

ID=11383545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99125642T DK1075837T3 (da) 1999-08-09 1999-12-22 Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse

Country Status (11)

Country Link
US (1) US6277829B1 (da)
EP (1) EP1075837B1 (da)
JP (1) JP2001089378A (da)
AT (1) ATE239448T1 (da)
CA (1) CA2315594A1 (da)
DE (1) DE69907664T2 (da)
DK (1) DK1075837T3 (da)
ES (1) ES2193658T3 (da)
IT (1) IT1313610B1 (da)
MX (1) MXPA00007530A (da)
PT (1) PT1075837E (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
WO2002007736A1 (en) * 2000-07-24 2002-01-31 Cadila Pharmaceuticals Limited The process for manufacturing of clear liquid pharmaceutical composition of azithromycin
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1284143A1 (en) * 2001-08-17 2003-02-19 Sifi S.p.A A process for the preparation of pharmaceutical formulations containing lactoferrin description
DK1446010T3 (da) * 2001-10-18 2009-06-22 Teva Pharma Stabiliseret azithromycin-sammensætning
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
ES2534904T3 (es) * 2003-01-22 2015-04-30 Senju Pharmaceutical Co., Ltd. Preparación de absorción percutánea para el tratamiento de enfermedad oftálmica, uso del mismo y método para la migración del remedio oftálmico en el tejido tópico en los ojos
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
KR101130252B1 (ko) 2004-07-02 2012-03-26 와카모토 세이야꾸 가부시끼가이샤 아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US9241918B2 (en) * 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
JP4968955B2 (ja) * 2005-05-10 2012-07-04 アルコン，インコーポレイテッド 眼用薬物、ポロキサミンおよびグリコール張度調整剤を含有する眼用懸濁液、ならびに眼の障害を処置するための医薬の製造のためのこの組成物の使用
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
FR2900575B1 (fr) * 2006-05-05 2008-10-17 Anteis Sa Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
WO2008106228A2 (en) * 2007-02-28 2008-09-04 Aciex Therapeutics, Inc. Methods and compositions for normalizing meibomian gland secretions
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
EP2285346A1 (en) * 2008-03-26 2011-02-23 Eric Donnenfeld Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics
MX2011000247A (es) * 2008-07-10 2011-03-30 Inspire Pharmaceuticals Inc Composicion farmaceutica para el tratamiento de blefaritis.
US20100190734A1 (en) * 2009-01-23 2010-07-29 Romulus Kimbro Brazzell Method of treating dry eye disease with azithromycin
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
CN103211755A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的阿奇霉素滴眼液的生产方法
US20180042953A1 (en) * 2012-06-08 2018-02-15 Obshchestvo S Ogranichennoy Otvetstvennostyu "Vik - Zdorovye Zhivotnykh" Antibacterial injectable pharmaceutical composition
RU2512683C2 (ru) * 2012-06-08 2014-04-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Антибактериальная инъекционная фармацевтическая композиция
CN103860515A (zh) * 2012-12-10 2014-06-18 中国科学院上海药物研究所 阿奇霉素渗透泵控释片及其制备方法
US9044508B2 (en) 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
PT2898888T (pt) * 2014-01-22 2019-07-16 Visufarma B V Composição que compreende iota-carragenina contra conjuntivite viral
RU2580631C1 (ru) * 2015-03-19 2016-04-10 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Антибактериальное лекарственное средство в форме мази для лечения глазных болезней у животных
RU2580630C1 (ru) * 2015-03-19 2016-04-10 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Антибактериальное лекарственное средство в форме капель для лечения глазных болезней у животных
CN110114119B (zh) * 2016-10-12 2022-05-31 Ps治疗有限公司 人工泪液、隐形眼镜和药物载体组合物及其使用方法
CN114796116A (zh) * 2022-05-17 2022-07-29 中山大学附属第六医院 一种阿奇霉素吸入剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1123279A (zh) * 1995-06-15 1996-05-29 沈家祥 阿奇霉素水溶性盐、其注射剂型以及它们的用途
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
DK0925789T4 (da) * 1997-12-02 2009-07-13 Pfizer Prod Inc Anvendelse af azithromycin ved topisk behandling af öjeninfektioner

Also Published As

Publication number Publication date
ATE239448T1 (de) 2003-05-15
JP2001089378A (ja) 2001-04-03
MXPA00007530A (es) 2002-06-04
DE69907664T2 (de) 2004-04-08
CA2315594A1 (en) 2001-02-09
IT1313610B1 (it) 2002-09-09
PT1075837E (pt) 2003-08-29
ES2193658T3 (es) 2003-11-01
EP1075837A3 (en) 2001-05-16
ITMI991803A0 (it) 1999-08-09
EP1075837A2 (en) 2001-02-14
ITMI991803A1 (it) 2001-02-09
EP1075837B1 (en) 2003-05-07
DE69907664D1 (de) 2003-06-12
US6277829B1 (en) 2001-08-21

Similar Documents

Publication Publication Date Title
DK1075837T3 (da) Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse
NO2022001I1 (no) Pazopanib
BRPI0307702B8 (pt) formulações de solução contendo anticorpo
BR0209918A (pt) Formas cristalinas da azitromicina
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
ATE277062T1 (de) Neue makrolidderivate
PT925789E (pt) Es oculares utilizacao de azitromicina no tratamento topico de infecco
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
WO2003072541A3 (en) Chemical compounds
EP1436279B8 (en) Chemical compounds
WO2002070537A3 (en) Fusidic acid derivatives
ATE241640T1 (de) Fusidinsäure-derivate
DE60123103D1 (de) Neue verbindungen
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
DE60214558D1 (de) 2-(AMINOMETHYL)TETRAHYDRO-9-OXA-1,3-DIAZACYCLOPENTAcAÜNAPHTHALINYLDERIVATE MIT ANTIPSYCHOTISCHER WIRKUNG
IL160490A0 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
DK1757601T3 (da) Quinolinderivater og deres anvendelse ved glaukom og myopi